CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Simon Dubreucq

OPENALEX: A5021953016↗ORCID: 0000-0002-4423-543X↗

Affiliations

Organizations

Centre Hospitalier de l’Université de Montréalauthorship · CA Université de Montréalauthorship · CA

Public evidence

3 connected articles

Concordance Between Urine Drug Screening and Self-Reported Use in the Context of a Pragmatic Randomized-Controlled Trial in People with <i>Prescription-Type</i> Opioid Use Disorder: Concordance entre le dépistage de drogues dans l'urine et l'usage autodéclaré dans le contexte d'un essai pragmatique contrôlé à répartition aléatoire chez des personnes présentant un trouble lié à l'usage d'opioïdes vendus sur ordonnance.2026 · Europe PMC Correlates of Engagement and Associations with Outcomes in a Cannabis Harm Reduction Mobile App for Youth with First-Episode Psychosis: Exploratory Findings from the CHAMPS Pilot Randomized Controlled Trial.2026 · PubMed Central Open Access Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Préférences des jeunes adultes souffrant de psychose pour les interventions de réduction des méfaits axées sur le cannabis : une étude transversale.2024 · Europe PMC

Registered research

Connected studies

A Randomized Pilot Trial of a Cannabis Harm Reduction e-Intervention (CHAMPS) for Young Adults With Early Psychosis Who Use Cannabisnct04968275

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Simon Dubreucq - Medical Cannabis Research Engine